In critical limb-threatening ischemia (CLTI), failed revascularization and pharmacotherapy substantially increase amputation and mortality risks. Mesenchymal stem cells (MSCs) are a promising ...
South Korean researchers have identified a new therapeutic target that could help overcome the limitations of anti-angiogenic ...
Elucidating the mechanical regulation of angiogenesis remains a challenge owing to the complexities of measuring cellular forces in this dynamic, multicellular and three-dimensional (3D) process.
Most tumors release various signaling molecules to support their incessant growth, invasion, and metastasis. Some of these molecules, known as tumor angiogenic factors (TAF), are able to stimulate the ...
BPC-157 and TB-500, originating from gastric and thymic sources respectively, both influence angiogenesis, cytoskeletal ...
Most tumors release various signaling molecules to support their incessant growth, invasion, and metastasis. Some of these molecules, known as tumor angiogenic factors (TAF), are able to stimulate the ...
A study by the University of Barcelona has discovered why the two main types of lung cancer—adenocarcinoma of the lung and squamous cell carcinoma—respond differently to anti-angiogenic therapy, that ...
Risk factors and outcomes for steroid-refractory immune-related hepatotoxicity in locally advanced and metastatic cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This ...
Safety in the use of granulocyte-colony stimulating factor during concurrent chemotherapy and thoracic radiotherapy in patients with small-cell lung cancer: A meta-analysis. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results